Rituximab induced cytokine release syndrome in an MS patient: A case report

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.

Cite

CITATION STYLE

APA

Etemadifar, M., Salari, M., Saeri, M., Sigari, A. A., & Ebrahimi Pelarti, S. (2021). Rituximab induced cytokine release syndrome in an MS patient: A case report. Clinical Case Reports, 9(7). https://doi.org/10.1002/ccr3.4407

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free